APTO - Aptose Biosciences Inc. (APTO) Q4 2023 Earnings Call Transcript
2024-03-26 20:38:02 ET
Aptose Biosciences Inc. (APTO)
Q4 2023 Earnings Conference Call
March 26, 2024 05:00 PM ET
Company Participants
Susan Pietropaolo - Managing Director-Corporate Communications & Investor Relations
William Rice - Chairman, President & Chief Executive Officer
Fletcher Payne - Senior Vice President and Chief Financial Officer
Rafael Bejar - Senior Vice President & Chief Medical Officer
Conference Call Participants
Soumit Roy - Jones Research
Presentation
Operator
Good afternoon. My name is Jonathan and I will be your conference operator today. I would like to welcome everyone to Aptose Biosciences Conference Call for the Fourth Quarter and Year Ended December 31, 2023. At this time, all participants are in a listen-only mode. After the speakers’ remarks, there will be a question-and-answer session. [Operator Instructions] As a reminder, this conference call may be recorded.
And now I'd like to introduce your host for today's program, Susan Pietropaolo. Please go ahead.
Susan Pietropaolo
Thank you, Jonathan. Good afternoon and welcome to the Aptose Biosciences conference call to discuss financial and operational results for the fourth quarter and year ended December 31, 2023. Earlier today, Aptose issued a press release relating to these financial results. The news release as well as related SEC filings are accessible on Aptose website....
Aptose Biosciences Inc. (APTO) Q4 2023 Earnings Call Transcript